Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

Regeneron Pharmaceuticals - 34 Year Stock Price History | REGN

Historical daily share price chart and data for Regeneron Pharmaceuticals since 1991 adjusted for splits and dividends. The latest closing stock price for Regeneron Pharmaceuticals as of July 16, 2025 is 547.93.
  • The all-time high Regeneron Pharmaceuticals stock closing price was 1198.45 on August 27, 2024.
  • The Regeneron Pharmaceuticals 52-week high stock price is 1211.20, which is 121.1% above the current share price.
  • The Regeneron Pharmaceuticals 52-week low stock price is 476.49, which is 13% below the current share price.
  • The average Regeneron Pharmaceuticals stock price for the last 52 weeks is 778.31.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
  
Regeneron Pharmaceuticals Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2025 615.1708 713.2180 743.7310 483.0700 547.9300 -22.87%
2024 965.6237 902.5050 1198.4500 699.9150 710.3660 -18.90%
2023 781.6642 718.4840 879.2690 678.6140 875.8690 21.73%
2022 660.6900 625.3710 764.2770 546.8380 719.5010 14.25%
2021 556.7856 481.5290 679.0830 445.4990 629.7790 30.72%
2020 530.8904 372.3210 656.3960 335.2530 481.7780 28.66%
2019 342.5594 371.4130 438.3580 272.7060 374.4450 0.53%
2018 350.6986 381.5450 407.3840 283.8150 372.4700 -0.65%
2017 421.3183 378.6530 525.0780 339.8110 374.9240 2.42%
2016 393.4125 515.1260 518.0480 330.1370 366.0780 -32.38%
2015 497.3582 409.0290 590.7670 395.7960 541.3730 32.33%
2014 332.7478 273.8330 433.7510 266.8820 409.1190 49.05%
2013 239.2000 180.7010 315.7570 157.9830 274.4810 60.89%
2012 130.4733 56.2744 187.2230 56.2744 170.5980 208.62%
2011 50.9658 33.7268 71.9910 32.5201 55.2772 68.84%
2010 26.1406 24.5621 33.5971 20.7327 32.7395 35.77%
2009 17.6683 18.6484 24.6718 12.0168 24.1133 31.70%
2008 18.9271 23.4951 24.7017 13.3132 18.3094 -23.98%
2007 20.4928 19.7554 28.5212 13.6223 24.0834 20.33%
2006 16.0708 15.8562 24.2131 11.0893 20.0147 26.23%
2005 8.2753 9.0151 16.7836 4.6172 15.8562 72.64%
2004 10.8053 15.0085 16.6739 6.8311 9.1846 -37.39%
2003 14.7150 19.0374 22.2485 5.8638 14.6694 -20.53%
2002 18.8325 27.8430 29.2292 11.3287 18.4590 -34.27%
2001 28.2992 35.4645 38.8925 20.5432 28.0824 -20.15%
2000 27.2595 12.2786 56.3442 11.4683 35.1684 176.59%
1999 7.7957 7.9156 12.7149 5.5472 12.7149 72.88%
1998 8.1252 8.8505 10.9073 5.8588 7.3547 -13.87%
1997 9.8584 17.0778 19.3216 6.4821 8.5389 -46.90%
1996 16.2180 13.2135 24.5571 11.8423 16.0805 26.47%
1995 9.5748 3.3034 16.4545 3.3034 12.7149 325.01%
1994 7.0163 15.2080 17.2024 2.9917 2.9917 -80.65%
1993 15.4592 11.9669 21.4407 10.9697 15.4573 29.17%
1992 12.9828 18.6983 22.4380 7.9779 11.9669 -33.79%
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $59.161B $14.202B
Regeneron is a biotechnology company focused on the discovery, development and commercialization of treatments targeting serious medical conditions. The company's portfolio boasts nine marketed drugs - Eylea, Dupixent, Praluent, Kevzara, Libtayo, Evkeeza, Inmazeb Arcalyst and Zaltrap. The company also developed an antibody cocktail for COVID-19, REGEN-COV. REGEN-COV is a cocktail of two monoclonal antibodies and was designed specifically to block the infectivity of SARS-CoV-2, the virus that causes COVID-19. Regeneron has a collaboration agreement with Roche for the same. While Regeneron has co-developed Eylea with Bayer's HealthCare unit, Praluent was co-developed with Sanofi. Regeneron collaborated with Bayer for the joint development and commercialization of co-formulated combinations of Eylea, rinucumab and nesvacumab for the treatment of ocular diseases or disorders outside the United States.
Stock Name Country Market Cap PE Ratio
AstraZeneca (AZN) United Kingdom $218.085B 16.28
Amgen (AMGN) United States $157.284B 14.09
Gilead Sciences (GILD) United States $135.663B 14.09
Vertex Pharmaceuticals (VRTX) United States $119.205B 0.00
Bristol Myers Squibb (BMY) United States $94.489B 6.33
CSL (CSLLY) Australia $78.820B 0.00
GSK (GSK) United Kingdom $77.431B 9.27
Alnylam Pharmaceuticals (ALNY) United States $40.566B 0.00
Argenex SE (ARGX) Netherlands $34.025B 92.66
BioNTech SE (BNTX) Germany $26.599B 0.00
Royalty Pharma (RPRX) United States $20.527B 8.67
Insmed (INSM) United States $19.516B 0.00
Biogen (BIIB) United States $18.682B 8.06
Illumina (ILMN) United States $15.379B 29.17
Genmab (GNMSF) Denmark $14.203B 14.52
Genmab (GMAB) Denmark $13.569B 15.22
Incyte (INCY) United States $13.211B 100.37
Moderna (MRNA) United States $12.213B 0.00
Exelixis (EXEL) United States $12.016B 20.40
BioMarin Pharmaceutical (BMRN) United States $10.858B 17.64
Ascendis Pharma (ASND) Denmark $10.683B 0.00
QIAGEN (QGEN) Netherlands $10.548B 20.52
Swedish Orphan Biovitrum (BIOVF) Sweden $10.413B 26.59
Exact Sciences (EXAS) United States $9.996B 0.00
Verona Pharma American Depositary Share (VRNA) United Kingdom $8.919B 0.00
Blueprint Medicines (BPMC) United States $8.354B 0.00
Bio-Techne Corp (TECH) United States $8.061B 30.07
Roivant Sciences (ROIV) United Kingdom $7.723B 0.00
Legend Biotech (LEGN) United States $7.275B 0.00
Revolution Medicines (RVMD) United States $7.043B 0.00
Bio-Rad Laboratories (BIO.B) United States $7.014B 24.41
Halozyme Therapeutics (HALO) United States $6.974B 13.35
Anbio Biotechnology (NNNN) Germany $6.871B 0.00
Jazz Pharmaceuticals (JAZZ) Ireland $6.795B 6.67
Regencell Bioscience Holdings (RGC) Hong Kong, SAR China $6.775B 0.00
Repligen (RGEN) United States $6.635B 74.28
TG Therapeutics (TGTX) United States $6.026B 158.17
Guardant Health (GH) United States $5.958B 0.00
Nuvalent (NUVL) United States $5.957B 0.00
Rhythm Pharmaceuticals (RYTM) United States $5.685B 0.00
Axsome Therapeutics (AXSM) United States $5.422B 0.00
Telix Pharmaceuticals (TLX) Australia $5.255B 0.00
Alkermes (ALKS) Ireland $4.757B 12.77
CRISPR Therapeutics AG (CRSP) Switzerland $4.554B 0.00
Vaxcyte (PCVX) United States $4.551B 0.00
Cytokinetics (CYTK) United States $4.539B 0.00
Metsera (MTSR) United States $4.515B 0.00
ADMA Biologics Inc (ADMA) United States $4.292B 32.11
Krystal Biotech (KRYS) United States $4.269B 32.90
Akero Therapeutics (AKRO) United States $4.126B 0.00
Zealand Pharma (ZLDPF) Denmark $4.016B 0.00
Zai Lab (ZLAB) China $3.909B 0.00
Avidity Biosciences (RNA) United States $3.820B 0.00
Merus (MRUS) Netherlands $3.806B 0.00
PTC Therapeutics (PTCT) United States $3.785B 6.59
Arcellx (ACLX) United States $3.756B 0.00
ACADIA Pharmaceuticals (ACAD) United States $3.684B 32.37
Scholar Rock Holding (SRRK) United States $3.680B 0.00
Viking Therapeutics (VKTX) United States $3.448B 0.00
Protagonist Therapeutics (PTGX) United States $3.429B 73.76
Ascentage Pharma Group - (AAPG) China $3.203B 0.00
MoonLake Immunotherapeutics (MLTX) Switzerland $3.179B 0.00
Immunovant (IMVT) United States $2.992B 0.00
Kymera Therapeutics (KYMR) United States $2.925B 0.00
HUTCHMED (China) (HCM) Hong Kong, SAR China $2.888B 0.00
Mirum Pharmaceuticals (MIRM) United States $2.575B 0.00
Ultragenyx Pharmaceutical (RARE) United States $2.572B 0.00
Alvotech (ALVO) Luxembourg $2.535B 14.50
Arrowhead Pharmaceuticals (ARWR) United States $2.435B 0.00
Apellis Pharmaceuticals (APLS) United States $2.432B 0.00
ImmunityBio (IBRX) United States $2.418B 0.00
Xenon Pharmaceuticals (XENE) Canada $2.416B 0.00
Ligand Pharmaceuticals (LGND) United States $2.398B 0.00
Agios Pharmaceuticals (AGIO) United States $2.270B 0.00
Bavarian Nordic (BVNRY) Denmark $2.197B 11.61
Twist Bioscience (TWST) United States $2.179B 0.00
Recursion Pharmaceuticals (RXRX) United States $2.122B 0.00
Denali Therapeutics (DNLI) United States $2.059B 0.00
Kiniksa Pharmaceuticals (KNSA) United Kingdom $2.050B 0.00
Belite Bio (BLTE) United States $2.016B 0.00
Harmony Biosciences Holdings (HRMY) United States $2.001B 13.30
Beam Therapeutics (BEAM) United States $1.969B 0.00
Disc Medicine (IRON) United States $1.949B 0.00
CG Oncology (CGON) United States $1.902B 0.00
IDEAYA Biosciences (IDYA) United States $1.877B 0.00
NovoCure (NVCR) Jersey $1.872B 0.00
Vericel (VCEL) United States $1.868B 1236.67
Arcutis Biotherapeutics (ARQT) United States $1.836B 0.00
Amicus Therapeutics (FOLD) United States $1.820B 197.00
Sarepta Therapeutics (SRPT) United States $1.790B 0.00
Immunocore Holdings (IMCR) United Kingdom $1.766B 0.00
Apogee Therapeutics (APGE) United States $1.710B 0.00
Tarsus Pharmaceuticals (TARS) United States $1.705B 0.00
Certara (CERT) United States $1.689B 31.55
Adaptive Biotechnologies (ADPT) United States $1.680B 0.00
89BIO (ETNB) United States $1.534B 0.00
Janux Therapeutics (JANX) United States $1.524B 0.00
Celldex Therapeutics (CLDX) United States $1.517B 0.00
Vera Therapeutics (VERA) United States $1.480B 0.00
Travere Therapeutics (TVTX) United States $1.455B 0.00
Edgewise Therapeutics (EWTX) United States $1.408B 0.00
Mesoblast (MESO) Australia $1.400B 0.00
ANI Pharmaceuticals (ANIP) United States $1.386B 14.29
GRAIL (GRAL) United States $1.386B 0.00
Biohaven (BHVN) United States $1.354B 0.00
Viridian Therapeutics (VRDN) United States $1.327B 0.00
Cogent Biosciences (COGT) United States $1.309B 0.00
Dynavax Technologies (DVAX) United States $1.254B 74.57
Liquidia Technologies (LQDA) United States $1.240B 0.00
CureVac (CVAC) Germany $1.214B 5.88
Pharvaris (PHVS) Netherlands $1.202B 0.00
WAVE Life Sciences (WVE) Singapore $1.199B 0.00
Intellia Therapeutics (NTLA) United States $1.189B 0.00
AbCellera Biologics (ABCL) Canada $1.176B 0.00
MannKind (MNKD) United States $1.170B 24.06
Novavax (NVAX) United States $1.114B 2.60
Structure Therapeutics (GPCR) United States $1.103B 0.00
Praxis Precision Medicines (PRAX) United States $1.057B 0.00
Pacira BioSciences (PCRX) United States $1.052B 10.01
Cidara Therapeutics (CDTX) United States $1.038B 0.00
Arcus Biosciences (RCUS) United States $0.956B 0.00
Replimune (REPL) United States $0.956B 0.00
Mineralys Therapeutics (MLYS) United States $0.953B 0.00
Sana Biotechnology (SANA) United States $0.942B 0.00
Oric Pharmaceuticals (ORIC) United States $0.936B 0.00
MiMedx (MDXG) United States $0.935B 22.61
Nurix Therapeutics (NRIX) United States $0.929B 0.00
Anavex Life Sciences (AVXL) United States $0.928B 0.00
Spyre Therapeutics (SYRE) United States $0.923B 0.00
LENZ Therapeutics (LENZ) United States $0.922B 0.00
Zymeworks (ZYME) United States $0.898B 0.00
Jyong Biotech (MENS) Taiwan $0.890B 0.00
NeoGenomics (NEO) United States $0.888B 0.00
Niagen Bioscience (NAGE) United States $0.873B 123.11
BGM Group (BGM) China $0.865B 0.00
GH Research (GHRS) Ireland $0.832B 0.00
Sionna Therapeutics (SION) United States $0.818B 0.00
Basilea Pharmaceutica AG (BPMUF) Switzerland $0.808B 0.00
Trevi Therapeutics (TRVI) United States $0.805B 0.00
Geron (GERN) United States $0.803B 0.00
Syndax Pharmaceuticals (SNDX) United States $0.793B 0.00
AnaptysBio (ANAB) United States $0.782B 0.00
Oculis Holding AG (OCS) Switzerland $0.781B 0.00
Pharming Group (PHGUF) Netherlands $0.772B 0.00
CorMedix Inc (CRMD) United States $0.771B 51.68
UniQure (QURE) Netherlands $0.765B 0.00
ArriVent BioPharma (AVBP) United States $0.740B 0.00
Vir Biotechnology (VIR) United States $0.733B 0.00
Immunome (IMNM) United States $0.731B 0.00
Nuvation Bio (NUVB) United States $0.725B 0.00
Immatics (IMTX) Germany $0.724B 0.00
Maze Therapeutics (MAZE) United States $0.701B 0.00
Pharming Group (PHAR) Netherlands $0.692B 0.00
MeiraGTx Holdings (MGTX) United States $0.689B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.677B 0.00
Gyre Therapeutics (GYRE) United States $0.671B 179.00
Day One Biopharmaceuticals (DAWN) United States $0.666B 0.00
Autolus Therapeutics (AUTL) United Kingdom $0.663B 0.00
Iovance Biotherapeutics (IOVA) United States $0.648B 0.00
Urogen Pharma (URGN) United States $0.647B 0.00
Sinovac Biotech (SVA) China $0.645B 0.00
Stoke Therapeutics (STOK) United States $0.642B 14.87
Tango Therapeutics (TNGX) United States $0.641B 0.00
Dianthus Therapeutics (DNTH) United States $0.612B 0.00
Mind Medicine (MindMed) (MNMD) United States $0.610B 0.00
Arbutus Biopharma (ABUS) United States $0.599B 0.00
Upstream Bio (UPB) United States $0.599B 0.00
Phathom Pharmaceuticals (PHAT) United States $0.596B 0.00
Keros Therapeutics (KROS) United States $0.579B 0.00
Prime Medicine (PRME) United States $0.577B 0.00
Sage Therapeutics (SAGE) United States $0.574B 0.00
Abivax SA (ABVX) France $0.562B 0.00
Bicara Therapeutics (BCAX) United States $0.558B 0.00
Ginkgo Bioworks Holdings (DNA) United States $0.552B 0.00
Precigen (PGEN) United States $0.546B 0.00
Castle Biosciences (CSTL) United States $0.545B 37.00
Arvinas (ARVN) United States $0.540B 0.00
Tyra Biosciences (TYRA) United States $0.538B 0.00
Bicycle Therapeutics (BCYC) United Kingdom $0.532B 0.00
Kura Oncology (KURA) United States $0.531B 0.00
Opthea (OPT) Australia $0.525B 0.00
Rapport Therapeutics (RAPP) United States $0.525B 0.00
Celcuity (CELC) United States $0.522B 0.00
Septerna (SEPN) United States $0.520B 0.00
Zenas BioPharma (ZBIO) United States $0.517B 0.00
Oxford BioMedica (OXBDF) United Kingdom $0.505B 0.00
ATyr Pharma (ATYR) United States $0.501B 0.00
Myriad Genetics (MYGN) United States $0.461B 0.00
MBX Biosciences (MBX) United States $0.448B 0.00
Terns Pharmaceuticals (TERN) United States $0.441B 0.00
Cullinan Therapeutics (CGEM) United States $0.440B 0.00
Rezolute (RZLT) United States $0.437B 0.00
Kamada (KMDA) Israel $0.435B 26.07
PureTech Health (PRTC) United States $0.431B 0.00
Fortrea Holdings (FTRE) United States $0.427B 11.80
Fulcrum Therapeutics (FULC) United States $0.423B 0.00
Solid Biosciences (SLDB) United States $0.418B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.416B 0.00
REGENXBIO (RGNX) United States $0.413B 0.00
Compass Therapeutics (CMPX) United States $0.412B 0.00
Cytek Biosciences (CTKB) United States $0.412B 0.00
Tectonic Therapeutic (TECX) United States $0.400B 0.00
Erasca (ERAS) United States $0.399B 0.00
ITeos Therapeutics (ITOS) United States $0.395B 0.00
Eton Pharmaceuticals (ETON) United States $0.387B 0.00
Northwest Biotherapeutics (NWBO) United States $0.385B 0.00
Vigil Neuroscience (VIGL) United States $0.384B 0.00
Emergent Biosolutions (EBS) United States $0.376B 0.00
Arcturus Therapeutics Holdings (ARCT) United States $0.357B 0.00
Astria Therapeutics (ATXS) United States $0.356B 0.00
Humacyte (HUMA) United States $0.354B 0.00
Cartesian Therapeutics (RNAC) United States $0.352B 0.00
Prothena (PRTA) Ireland $0.335B 0.00
Inhibrx Biosciences (INBX) United States $0.332B 0.20
Aura Biosciences (AURA) United States $0.330B 0.00
Gossamer Bio (GOSS) United States $0.330B 0.00
Absci (ABSI) United States $0.328B 0.00
Amarin (AMRN) Ireland $0.327B 0.00
Benitec Biopharma (BNTC) United States $0.327B 0.00
Foghorn Therapeutics (FHTX) United States $0.323B 0.00
ADC Therapeutics SA (ADCT) Switzerland $0.322B 0.00
Monte Rosa Therapeutics (GLUE) United States $0.322B 65.38
Inventiva S.A (IVA) France $0.319B 0.00
XOMA Royalty (XOMA) United States $0.314B 0.00
Olema Pharmaceuticals (OLMA) United States $0.314B 0.00
Candel Therapeutics (CADL) United States $0.313B 0.00
Ocugen (OCGN) United States $0.312B 0.00
Palvella Therapeutics (PVLA) United States $0.306B 0.00
Neurogene (NGNE) United States $0.306B 0.00
Atea Pharmaceuticals (AVIR) United States $0.306B 0.00
Abeona Therapeutics (ABEO) United States $0.304B 0.00
Rocket Pharmaceuticals (RCKT) United States $0.300B 0.00
Sagimet Biosciences (SGMT) United States $0.291B 0.00
Lifecore Biomedical (LFCR) United States $0.285B 0.00
Corvus Pharmaceuticals (CRVS) United States $0.284B 0.00
Vanda Pharmaceuticals (VNDA) United States $0.281B 0.00
Vor Biopharma (VOR) $0.281B 0.00
DBV Technologies S.A (DBVT) France $0.278B 0.00
Annexon (ANNX) United States $0.274B 0.00
Cardiff Oncology (CRDF) United States $0.274B 0.00
Mereo BioPharma Group - (MREO) United Kingdom $0.272B 0.00
Allogene Therapeutics (ALLO) United States $0.271B 0.00
Verastem (VSTM) United States $0.269B 0.00
Zhengye Biotechnology Holding (ZYBT) China $0.262B 0.00
Kodiak Sciences (KOD) United States $0.254B 0.00
Aardvark Therapeutics (AARD) United States $0.252B 0.00
ProQR Therapeutics (PRQR) Netherlands $0.248B 0.00
Third Harmonic Bio (THRD) United States $0.246B 0.00
Tvardi Therapeutics (TVRD) United States $0.244B 0.00
Monopar Therapeutics (MNPR) United States $0.243B 0.00
Entrada Therapeutics (TRDA) United States $0.242B 7.86
Adherex Technologies (FENC) United States $0.240B 0.00
Prima BioMed (IMMP) Australia $0.238B 0.00
Alpha Teknova (TKNO) United States $0.235B 0.00
Neumora Therapeutics (NMRA) United States $0.235B 0.00
Codexis (CDXS) United States $0.233B 0.00
ScPharmaceuticals (SCPH) United States $0.232B 0.00
Eledon Pharmaceuticals (ELDN) United States $0.231B 0.00
Editas Medicine (EDIT) United States $0.230B 0.00
Crescent Biopharma (CBIO) United States $0.230B 0.00
MaxCyte (MXCT) United States $0.225B 0.00
Design Therapeutics (DSGN) United States $0.223B 0.00
Semper Paratus Acquisition (TVGN) United States $0.221B 0.00
Adocia (ADOCY) France $0.216B 0.00
Ventyx Biosciences (VTYX) United States $0.216B 0.00
CARGO Therapeutics (CRGX) United States $0.213B 0.00
AC Immune (ACIU) Switzerland $0.206B 0.00
Eupraxia Pharmaceuticals (EPRX) Canada $0.194B 0.00
CytomX Therapeutics (CTMX) United States $0.193B 5.00
Y-mAbs Therapeutics (YMAB) United States $0.191B 0.00
Alumis (ALMS) United States $0.190B 0.00
SELLAS Life Sciences (SLS) United States $0.190B 0.00
GENFIT S.A (GNFT) France $0.190B 0.00
DiaMedica Therapeutics (DMAC) United States $0.184B 0.00
EnGene Holdings (ENGN) Canada $0.179B 0.00
Rapt Therapeutics (RAPT) United States $0.175B 0.00
Nuvectis Pharma (NVCT) United States $0.173B 0.00
Tiziana Life Sciences (TLSA) United Kingdom $0.172B 0.00
Puma Biotechnology (PBYI) United States $0.172B 4.49
Bright Minds Biosciences (DRUG) United States $0.172B 0.00
I-Mab (IMAB) United States $0.171B 0.00
Agenus (AGEN) United States $0.171B 0.00
Voyager Therapeutics (VYGR) United States $0.170B 0.00
Black Diamond Therapeutics (BDTX) United States $0.168B 49.17
BioStem Technologies (BSEM) $0.167B 6.80
Alpha Cognition (ACOG) Canada $0.167B 0.00
Kyverna Therapeutics (KYTX) United States $0.165B 0.00
Innate Pharma S.A (IPHA) France $0.163B 0.00
BioAge Labs (BIOA) United States $0.162B 0.00
Anika Therapeutics (ANIK) United States $0.158B 0.00
Instil Bio (TIL) United States $0.157B 0.00
Cuprina Holdings (Cayman) (CUPR) Singapore $0.155B 0.00
Alector (ALEC) United States $0.155B 0.00
Immuneering (IMRX) United States $0.150B 0.00
C4 Therapeutics (CCCC) United States $0.150B 0.00
Caribou Biosciences (CRBU) United States $0.150B 0.00
Elicio Therapeutics (ELTX) United States $0.147B 0.00
Theratechnologies (THTX) Canada $0.144B 0.00
Molecular Partners AG (MOLN) Switzerland $0.144B 0.00
Compugen (CGEN) Israel $0.141B 0.00
Enanta Pharmaceuticals (ENTA) United States $0.141B 0.00
Spero Therapeutics (SPRO) United States $0.139B 0.00
Greenwich LifeSciences (GLSI) United States $0.135B 0.00
23andMe Holding (MEHCQ) United States $0.134B 0.00
Fate Therapeutics (FATE) United States $0.130B 0.00
Nkarta (NKTX) United States $0.129B 0.00
Seres Therapeutics (MCRB) United States $0.128B 0.00
Seer (SEER) United States $0.124B 0.00
BioHarvest Sciences (BHST) Canada $0.118B 0.00
Cellectis S.A (CLLS) France $0.117B 0.00
Actuate Therapeutics (ACTU) United States $0.117B 0.00
Genelux (GNLX) United States $0.116B 0.00
Skye Bioscience (SKYE) United States $0.116B 0.00
Tenaya Therapeutics (TNYA) United States $0.112B 0.00
IO Biotech (IOBT) Denmark $0.112B 0.00
Sangamo Therapeutics (SGMO) United States $0.112B 0.00
Orchestra BioMed Holdings (OBIO) United States $0.112B 0.00
MiNK Therapeutics (INKT) United States $0.112B 0.00
Citius Oncology (CTOR) United States $0.110B 0.00
HilleVax (HLVX) United States $0.107B 0.00
Oncolytics Biotech (ONCY) Canada $0.107B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.103B 0.00
Coya Therapeutics (COYA) United States $0.101B 0.00
Prenetics Global (PRE) Hong Kong, SAR China $0.101B 0.00
TuHURA Biosciences (HURA) United States $0.100B 0.00
TScan Therapeutics (TCRX) United States $0.100B 0.00
Coherus Oncology (CHRS) United States $0.098B 0.00
Contineum Therapeutics (CTNM) United States $0.098B 0.00
Zentalis Pharmaceuticals (ZNTL) United States $0.096B 0.00
BeyondSpring (BYSI) United States $0.093B 0.00
OKYO Pharma (OKYO) $0.093B 0.00
Climb Bio (CLYM) United States $0.093B 0.00
Whitehawk Therapeutics (WHWK) United States $0.091B 0.00
Nautilus Biotechnology (NAUT) United States $0.091B 0.00
Adagene (ADAG) China $0.090B 0.00
Zura Bio (ZURA) United States $0.089B 0.00
Entera Bio (ENTX) Israel $0.085B 0.00
Pliant Therapeutics (PLRX) United States $0.085B 0.00
XBiotech (XBIT) United States $0.084B 0.00
EXoZymes (EXOZ) United States $0.083B 0.00
Cabaletta Bio (CABA) United States $0.083B 0.00
Invivyd (IVVD) United States $0.082B 0.00
Elutia (ELUT) United States $0.081B 0.00
Connect Biopharma Holdings (CNTB) United States $0.081B 0.00
IGM Biosciences (IGMS) United States $0.081B 0.00
Immunic (IMUX) United States $0.080B 0.00
TELA Bio (TELA) United States $0.080B 0.00
Acumen Pharmaceuticals (ABOS) United States $0.079B 0.00
Milestone Pharmaceuticals (MIST) Canada $0.079B 0.00
Quince Therapeutics (QNCX) United States $0.079B 0.00
Immix Biopharma (IMMX) United States $0.077B 0.00
Oncobiologics (OTLK) United States $0.076B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $0.072B 0.00
Genenta Science S.p.A (GNTA) Italy $0.070B 0.00
Alto Neuroscience (ANRO) United States $0.070B 0.00
Ikena Oncology (IKNA) United States $0.069B 0.00
Biomea Fusion (BMEA) United States $0.067B 0.00
Opus Genetics (IRD) United States $0.066B 0.00
VistaGen Therapeutics (VTGN) United States $0.066B 0.00
Anebulo Pharmaceuticals (ANEB) United States $0.065B 0.00
Clearside Biomedical (CLSD) United States $0.064B 0.00
Sutro Biopharma (STRO) United States $0.063B 0.00
Adicet Bio (ACET) United States $0.063B 0.00
CervoMed (CRVO) United States $0.063B 0.00
Forte Biosciences (FBRX) United States $0.062B 0.00
Repare Therapeutics (RPTX) Canada $0.061B 0.00
ABVC BioPharma (ABVC) United States $0.061B 0.00
MediciNova (MNOV) United States $0.060B 0.00
Applied Therapeutics (APLT) United States $0.060B 0.00
Celularity (CELU) United States $0.059B 0.00
Werewolf Therapeutics (HOWL) United States $0.059B 0.00
Adlai Nortye (ANL) Cayman Islands $0.058B 0.00
Earth Science Tech (ETST) United States $0.057B 0.00
Fortress Biotech (FBIO) United States $0.057B 0.00
Quantum Biopharma (QNTM) Canada $0.056B 0.00
Atara Biotherapeutics (ATRA) United States $0.055B 0.00
Adverum Biotechnologies (ADVM) United States $0.055B 0.00
InflaRx (IFRX) Germany $0.055B 0.00
VTv Therapeutics (VTVT) United States $0.054B 0.00
PDS Biotechnology (PDSB) United States $0.053B 0.00
Cue Biopharma (CUE) United States $0.053B 0.00
Annovis Bio (ANVS) United States $0.052B 0.00
Aligos Therapeutics (ALGS) United States $0.052B 0.00
Artiva Biotherapeutics (ARTV) United States $0.052B 0.00
ZIVO Bioscience (ZIVO) United States $0.051B 0.00
Jasper Therapeutics (JSPR) United States $0.050B 0.00
Precision BioSciences (DTIL) United States $0.049B 0.00
Senti Biosciences (SNTI) United States $0.049B 0.00
INmune Bio (INMB) United States $0.049B 0.00
Renovaro (RENB) United States $0.048B 0.00
RenovoRx (RNXT) United States $0.048B 0.00
Inovio Pharmaceuticals (INO) United States $0.048B 0.00
Scilex Holding (SCLX) United States $0.047B 0.00
Kalaris Therapeutics (KLRS) United States $0.045B 0.00
Grace Therapeutics (GRCE) Canada $0.044B 0.00
Exicure (XCUR) United States $0.043B 0.00
Barinthus Biotherapeutics (BRNS) United Kingdom $0.041B 0.00
Mersana Therapeutics (MRSN) United States $0.041B 0.00
PepGen (PEPG) United States $0.041B 0.00
Lantern Pharma (LTRN) United States $0.041B 0.00
Medicus Pharma (MDCX) United States $0.040B 0.00
Alterity Therapeutics - (ATHE) Australia $0.040B 0.00
Pluri (PLUR) Israel $0.039B 0.00
Shattuck Labs (STTK) United States $0.038B 0.00
Xilio Therapeutics (XLO) United States $0.037B 0.00
LAVA Therapeutics (LVTX) Netherlands $0.037B 0.00
KALA BIO (KALA) United States $0.035B 0.00
Cognition Therapeutics (CGTX) United States $0.035B 0.00
Akari Therapeutics (AKTX) United Kingdom $0.035B 0.00
Coeptis Therapeutics Holdings (COEP) United States $0.035B 0.00
OnKure Therapeutics (OKUR) United States $0.034B 0.00
Kezar Life Sciences (KZR) United States $0.034B 0.00
Radiopharm Theranostics - (RADX) Australia $0.033B 0.00
Biodexa Pharmaceuticals (BDRX) United Kingdom $0.032B 0.00
AN2 Therapeutics (ANTX) United States $0.032B 0.00
Rein Therapeutics (RNTX) United States $0.031B 0.00
Sonnet BioTherapeutics Holdings (SONN) United States $0.031B 0.00
Estrella Immunopharma (ESLA) United States $0.031B 0.00
Clene (CLNN) United States $0.031B 0.00
Femasys (FEMY) United States $0.030B 0.00
Dyadic (DYAI) United States $0.030B 0.00
CAMP4 Therapeutics (CAMP) United States $0.029B 0.00
CalciMedica (CALC) United States $0.029B 0.00
Generation Bio (GBIO) United States $0.029B 0.00
MIRA Pharmaceuticals (MIRA) United States $0.028B 0.00
FibroBiologics (FBLG) United States $0.028B 0.00
NeuroSense Therapeutics (NRSN) Israel $0.027B 0.00
Rani Therapeutics Holdings (RANI) United States $0.027B 0.00
Ovid Therapeutics (OVID) United States $0.026B 0.00
Q32 Bio (QTTB) United States $0.025B 0.00
Dare Bioscience (DARE) United States $0.025B 0.00
Boundless Bio (BOLD) United States $0.025B 0.00
ALX Oncology Holdings (ALXO) United States $0.025B 0.00
Tenax Therapeutics (TENX) United States $0.025B 0.00
Cadrenal Therapeutics (CVKD) United States $0.024B 0.00
SAB Biotherapeutics (SABS) United States $0.024B 0.00
Lisata Therapeutics (LSTA) United States $0.023B 0.00
BioAtla (BCAB) United States $0.023B 0.00
Elevation Oncology (ELEV) United States $0.022B 0.00
CollPlant Biotechnologies (CLGN) Israel $0.022B 0.00
Longeveron (LGVN) United States $0.022B 0.00
Chemomab Therapeutics (CMMB) Israel $0.022B 0.00
Cyclacel Pharmaceuticals (CYCC) $0.020B 0.00
Aytu BioPharma (AYTU) United States $0.019B 0.00
Curis (CRIS) United States $0.019B 0.00
Cingulate (CING) United States $0.019B 0.00
Passage Bio (PASG) United States $0.019B 0.00
Hoth Therapeutics (HOTH) United States $0.018B 0.00
Advanced Biomed (ADVB) United States $0.017B 0.00
Rallybio (RLYB) United States $0.017B 0.00
Gelteq (GELS) Australia $0.016B 0.00
Lexaria Bioscience (LEXX) Canada $0.016B 0.00
Aspire Biopharma Holdings (ASBP) United States $0.016B 0.00
Athira Pharma (ATHA) United States $0.015B 0.00
Synlogic (SYBX) United States $0.015B 0.00
Edesa Biotech (EDSA) Canada $0.015B 0.00
Allarity Therapeutics (ALLR) United States $0.015B 0.00
Promis Neurosciences (PMN) Canada $0.014B 0.00
HOOKIPA Pharma (HOOK) United States $0.014B 0.00
Neuphoria Therapeutics (NEUP) Australia $0.014B 0.00
Leap Therapeutics (LPTX) United States $0.014B 0.00
Beyond Air (XAIR) United States $0.014B 0.00
Equillium (EQ) United States $0.014B 0.00
Synaptogenix (TAOX) United States $0.013B 0.00
MetaVia (MTVA) United States $0.013B 0.00
Acurx Pharmaceuticals (ACXP) United States $0.013B 0.00
NextCure (NXTC) United States $0.013B 0.00
BioCardia (BCDA) United States $0.013B 0.00
IBio (IBIO) United States $0.012B 0.00
Abpro Holdings (ABP) United States $0.012B 0.00
Brainstorm Cell Therapeutics (BCLI) United States $0.012B 0.00
Biorestorative Therapies (BRTX) United States $0.012B 0.00
BioXcel Therapeutics (BTAI) United States $0.012B 0.00
Bionano Genomics (BNGO) United States $0.011B 0.00
COSCIENS Biopharma (CSCI) Canada $0.011B 0.00
GeoVax Labs (GOVX) United States $0.011B 0.00
IMMURON (IMRN) Australia $0.011B 0.00
Novogen (KZIA) Australia $0.011B 0.00
Bolt Biotherapeutics (BOLT) United States $0.011B 0.00
Mustang Bio (MBIO) United States $0.010B 0.00
Cyclerion Therapeutics (CYCN) United States $0.010B 0.00
Sensei Biotherapeutics (SNSE) United States $0.010B 0.00
Lixte Biotechnology Holdings (LIXT) United States $0.010B 0.00
LakeShore Biopharma (LSB) China $0.010B 0.00
GENPREX (GNPX) United States $0.010B 0.00
Imunon (IMNN) United States $0.009B 0.00
Aprea Therapeutics (APRE) United States $0.009B 0.00
Dogwood Therapeutics (DWTX) United States $0.009B 0.00
Moleculin Biotech (MBRX) United States $0.009B 0.00
Artelo Biosciences (ARTL) United States $0.009B 0.00
X4 Pharmaceuticals (XFOR) United States $0.009B 0.00
Intensity Therapeutics (INTS) United States $0.008B 0.00
BioAffinity Technologies (BIAF) United States $0.008B 0.00
Turnstone Biologics (TSBX) United States $0.008B 0.00
Biofrontera (BFRI) United States $0.008B 0.00
Cardio Diagnostics Holdings (CDIO) United States $0.008B 0.00
Jade Biosciences (JBIO) United States $0.007B 0.00
Sunshine Biopharma (SBFM) United States $0.007B 0.00
Mainz Biomed (MYNZ) Germany $0.007B 0.00
Evogene (EVGN) Israel $0.007B 0.00
Apollomics (APLM) United States $0.007B 0.00
Silexion Therapeutics Corp (SLXN) Israel $0.007B 0.00
GT Biopharma (GTBP) United States $0.007B 0.00
IN8bio (INAB) United States $0.007B 0.00
Creative Medical Technology Holdings (CELZ) United States $0.006B 0.00
Arcadia Biosciences (RKDA) United States $0.006B 0.00
Purple Biotech (PPBT) Israel $0.006B 0.00
HCW Biologics (HCWB) United States $0.006B 0.00
Portage Biotech (PRTG) $0.006B 0.00
Polyrizon (PLRZ) Israel $0.006B 0.00
180 Life Sciences (ATNF) United States $0.005B 0.00
BRIACELL THERAP (BCTX) Canada $0.005B 0.00
Pasithea Therapeutics (KTTA) United States $0.005B 0.00
Ensysce Biosciences (ENSC) United States $0.005B 0.00
Avalon GloboCare (ALBT) United States $0.005B 0.00
VivoSim Labs (VIVS) United States $0.005B 0.00
CNS Pharmaceuticals (CNSP) United States $0.005B 0.00
Galecto (GLTO) Denmark $0.005B 0.00
Dermata Therapeutics (DRMA) United States $0.005B 0.00
GRI Bio (GRI) United States $0.004B 0.00
Tharimmune (THAR) United States $0.004B 0.00
Revelation Biosciences (REVB) United States $0.004B 0.00
Titan Pharmaceuticals (TTNP) United States $0.004B 0.00
Soligenix (SNGX) United States $0.004B 0.00
Adial Pharmaceuticals (ADIL) United States $0.004B 0.00
Virax Biolabs Group (VRAX) United Kingdom $0.004B 0.00
Palisade Bio (PALI) United States $0.004B 0.00
Enveric Biosciences (ENVB) United States $0.003B 0.00
Windtree Therapeutics (WINT) United States $0.003B 0.00
AquaBounty Technologies (AQB) United States $0.003B 0.00
Psyence Biomedical (PBM) Canada $0.003B 0.00
ZyVersa Therapeutics (ZVSA) United States $0.003B 0.00
Silo Pharma (SILO) United States $0.003B 0.00
Alzamend Neuro (ALZN) United States $0.003B 0.00
Onconetix (ONCO) United States $0.002B 0.00
Entero Therapeutics (ENTO) United States $0.002B 0.00
Scinai Immunotherapeutics (SCNI) Israel $0.002B 0.00
Aptevo Therapeutics (APVO) United States $0.002B 0.00
Atrinsic (PTIX) United States $0.002B 0.00
Bone Biologics (BBLG) United States $0.002B 0.00
NuCana (NCNA) United Kingdom $0.000B 0.00
Aceragen (ACGN) United States $0.000B 0.00
ARAVIVE, INC (ARAV) United States $0.000B 0.00
Clovis Oncology (CLVSQ) United States $0.000B 0.00
Cocrystal Pharma (COCP) United States $0.000B 0.00
Celyad SA (CYAD) Belgium $0.000B 0.00
CytoMed Therapeutics (GDTC) Singapore $0.000B 0.00
Galapagos (GLPG) Belgium $0.000B 0.00
Motif Bio Plc (MTFB) United Kingdom $0.000B 0.00
PDL BioPharma (PDLI) United States $0.000B 0.00
Pulmatrix (PULM) United States $0.000B 0.00
TFF Pharmaceuticals (TFFP) United States $0.000B 0.00
VectivBio Holding AG (VECT) Switzerland $0.000B 0.00